PortfoliosLab logoPortfoliosLab logo
ETON vs. GREK
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ETON vs. GREK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eton Pharmaceuticals Inc (ETON) and Global X MSCI Greece ETF (GREK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ETON achieves a 86.81% return, which is significantly higher than GREK's 15.45% return.


ETON

1D
-1.62%
1M
2.50%
YTD
86.81%
6M
89.16%
1Y
117.71%
3Y*
102.22%
5Y*
36.00%
10Y*

GREK

1D
0.87%
1M
5.63%
YTD
15.45%
6M
15.54%
1Y
38.63%
3Y*
32.67%
5Y*
24.30%
10Y*
16.01%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ETON vs. GREK - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ETON
Eton Pharmaceuticals Inc
86.81%26.95%204.11%55.32%-34.27%-47.23%12.92%17.65%-4.23%
GREK
Global X MSCI Greece ETF
15.45%76.11%9.53%42.72%3.64%6.14%-13.89%50.20%-5.64%

Correlation

The correlation between ETON and GREK is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Nov 13, 2018

0.15

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ETON vs. GREK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ETON
ETON Risk / Return Rank: 8787
Overall Rank
ETON Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
ETON Sortino Ratio Rank: 8888
Sortino Ratio Rank
ETON Omega Ratio Rank: 8787
Omega Ratio Rank
ETON Calmar Ratio Rank: 8585
Calmar Ratio Rank
ETON Martin Ratio Rank: 8282
Martin Ratio Rank

GREK
GREK Risk / Return Rank: 4949
Overall Rank
GREK Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
GREK Sortino Ratio Rank: 5757
Sortino Ratio Rank
GREK Omega Ratio Rank: 5151
Omega Ratio Rank
GREK Calmar Ratio Rank: 4141
Calmar Ratio Rank
GREK Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ETON vs. GREK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and Global X MSCI Greece ETF (GREK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ETONGREKDifference
Sharpe ratioReturn per unit of total volatility

+0.57

Sortino ratioReturn per unit of downside risk

+0.46

Omega ratioGain probability vs. loss probability

1.36

1.28

+0.08

Calmar ratioReturn relative to maximum drawdown

3.27

1.82

+1.45

Martin ratioReturn relative to average drawdown

6.73

5.62

+1.11

ETON vs. GREK - Sharpe Ratio Comparison

The current ETON Sharpe Ratio is 2.16, which is higher than the GREK Sharpe Ratio of 1.59. The chart below compares the historical Sharpe Ratios of ETON and GREK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ETON vs. GREK - Drawdown Comparison

The maximum ETON drawdown since its inception was -79.94%, roughly equal to the maximum GREK drawdown of -79.50%. Use the drawdown chart below to compare losses from any high point for ETON and GREK.


Loading charts...

Drawdown Indicators


ETONGREKDifference

Max Drawdown

Largest peak-to-trough decline

-79.94%

-79.50%

-0.44%

Max Drawdown (1Y)

Largest decline over 1 year

-36.17%

-21.32%

-14.85%

Max Drawdown (3Y)

Largest decline over 3 years

-45.65%

-22.63%

-23.02%

Max Drawdown (5Y)

Largest decline over 5 years

-70.42%

-30.46%

-39.96%

Max Drawdown (10Y)

Largest decline over 10 years

-57.04%

Current Drawdown

Current decline from peak

-9.74%

-1.44%

-8.30%

Average Drawdown

Average peak-to-trough decline

-37.58%

-45.25%

+7.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.56%

6.90%

+10.66%

Volatility

ETON vs. GREK - Volatility Comparison

Eton Pharmaceuticals Inc (ETON) has a higher volatility of 17.63% compared to Global X MSCI Greece ETF (GREK) at 8.69%. This indicates that ETON's price experiences larger fluctuations and is considered to be riskier than GREK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ETONGREKDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.63%

8.69%

+8.94%

Volatility (6M)

Calculated over the trailing 6-month period

40.49%

20.65%

+19.84%

Volatility (1Y)

Calculated over the trailing 1-year period

54.85%

24.35%

+30.50%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

63.41%

24.44%

+38.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

63.87%

29.71%

+34.16%

Dividends

ETON vs. GREK - Dividend Comparison

ETON has not paid dividends to shareholders, while GREK's dividend yield for the trailing twelve months is around 3.00%.


PositionTTM20252024202320222021202020192018201720162015
ETON
Eton Pharmaceuticals Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
GREK
Global X MSCI Greece ETF
3.00%3.46%4.63%2.61%2.82%2.16%2.62%2.25%2.41%2.13%1.95%1.52%

Frequently Asked Questions


ETON and GREK have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ETON has higher volatility (17.63%) compared to GREK (8.69%). In terms of maximum drawdown, ETON dropped -79.94% vs GREK's -79.50%.

ETON currently has the higher Sharpe Ratio (2.16 vs 1.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ETON and GREK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer